Matthew Beard
Ipsen
26 Papers
102 Citations
Matthew Beard is an academic researcher from Ipsen. The author has contributed to research in topics: Cleavage (embryo) & Clostridium botulinum. The author has an hindex of 8, co-authored 26 publications.
Chat about Author
Papers
Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
Liang Tao,Lisheng Peng,Lisheng Peng,Ronnie P.-A. Berntsson,Ronnie P.-A. Berntsson,Sai Man Liu,SunHyun Park,Feifan Yu,Christopher D. Boone,Shilpa Palan,Matthew Beard,P. E. Chabrier,Pål Stenmark,Johannes Krupp,Min Dong +14 more
TL;DR: Mutant botulinum neurotoxin B containing E1191M/S1199Y exhibits ~11-fold higher efficacy in blocking neurotransmission than wild-type botulinu toxin B in neurons expressing human synaptotagmin II, demonstrating that enhancing receptor binding increases the overall efficacy at functional levels.
Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models
Mark Elliott,Christine Favre-Guilmard,Sai Man Liu,Jacquie Maignel,Geoffrey Masuyer,Matthew Beard,Christopher D. Boone,Denis Carré,Mikhail Kalinichev,Stéphane Lezmi,Imran Mir,Camille Nicoleau,Shilpa Palan,Cindy Perier,Elsa Raban,Sicai Zhang,Min Dong,Pål Stenmark,Pål Stenmark,Johannes Krupp +19 more
TL;DR: The preclinical characterization of two engineered botulinum neurotoxin serotype B proteins with significant therapeutic potential are reported and it is demonstrated that neuronal surface receptor binding limits the clinical efficacy of unmodified BoNT/B and that modified Bo NT/B proteins have promising clinical potential.
43
Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity
TL;DR: This article discusses site directed mutagenesis, used to affect the biological properties of BoNTs, including approaches to alter their binding to neurons and to alter the specificity and kinetics of substrate cleavage.
Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.
Gavin Hackett,Kevin Moore,David Burgin,Fraser Hornby,Bryony Gray,Mark Elliott,Imran Mir,Matthew Beard +7 more
TL;DR: P purification and characterization of enzymatically active, and of inactive nontoxic, recombinant forms of BoNT/FA are reported as tractable alternatives to purifying this neurotoxin from native Clostridium botulinum.
21
Engineering botulinum neurotoxin domains for activation by toxin light chain.
Patrick Stancombe,Geoffrey Masuyer,Ian Birch-Machin,Matthew Beard,Keith Foster,John A. Chaddock,K. Ravi Acharya +6 more
TL;DR: These engineered TSI backbones are capable of translocating their enzymatic domains to target intracellular SNARE proteins and are also investigative tools with which to further the understanding of endopeptidase activity of light chain in SNARE interactions.
20